C53.0
Malignant neoplasm of endocervix
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the endocervix, also known as cervical cancer, is a serious condition characterized by the uncontrolled growth of cancerous cells in the lining of the endocervical canal. The endocervix is the innermost part of the cervix, connecting the uterus to the vagina. This form of cancer can develop gradually over time and may not produce noticeable symptoms in its early stages. Early detection and treatment are crucial for improving outcomes and managing the disease effectively.
Causes & Symptoms
Clinical Causes: Persistent infection with high-risk human papillomavirus (HPV) types, especially HPV 16 and 18 Smoking, which can weaken the immune system and impair the body's ability to fight HPV infections Having multiple sexual partners or early sexual activity, increasing exposure to HPV Weakened immune system due to conditions like HIV/AIDS or immune-suppressing medications Long-term use of birth control methods, such as oral contraceptives (though evidence is mixed) History of other sexually transmitted diseases Family history of cervical cancer or other cancers
Key Symptoms: Abnormal vaginal bleeding, such as bleeding between periods or after menopause Unusual vaginal discharge that may be watery, bloody, or foul-smelling Pain during sexual intercourse (dyspareunia) Pelvic pain or discomfort Bleeding after pelvic examination or Pap smear Unexplained weight loss or fatigue in advanced stages
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of screening and diagnostic procedures, including:
Treatment Protocols: Treatment options depend on the stage of the cancer and overall health, and may include:
Clinical Advice & FAQs
Billing Guidance
Is C53.0 a billable ICD-10 code?
Yes, C53.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C53.0?
Clinical documentation must specify the nature of Malignant neoplasm of endocervix and any associated comorbidities for accurate reporting.
Cite this Clinical Reference